Jounce Therapeutics' IPO

Jounce Therapeutics raised a round of funding on January 27, 2017. Investors include Public.

Jounce Therapeutics is dedicated to transforming the treatment of cancer through discovering and developing novel cancer immunotherapies with the potential to drive significantly more durable response…

Articles about Jounce Therapeutics' IPO: